Pharma Journalist -

ANI Pharmaceuticals, Inc. announced the launch of its first Pindolol Tablets, 5mg and 10mg. ANI's President and CEO, Arthur S. Przybyl said that they are excited to launch the first…
Read More...

BioAtla, announced that Dr. Yong Ben has been appointed as Chief Medical Officer. Dr. Yong Ben joins BioAtla with over 20 years of industry and academic experience in oncology.…
Read More...

DURECT announced that it has signed a $293 Million Agreement with Sandoz to develop and market DURECT's POSIMIR (SABER-Bupivacaine) in the United States. According to the terms of…
Read More...

Cosmo Pharmaceuticals announced that clinical trial of Eleview in comparison to a standard saline solution in subjects undergoing Endoscopic Mucosal Resection (EMR) of colonic lesions…
Read More...

U.S. FDA has granted approval for MT Pharma America, Inc. RADICAVA (edaravone), as an intravenous infusion treatment for amyotrophic lateral sclerosis (ALS).  People given RADICAVA…
Read More...

Teva Pharmaceutical and Active Biotech announced that the results from the CONCERTO trial did not meet primary endpoint. The trial was based on patients with relapsing-remitting…
Read More...

BIOLASE announced that it will be initiating a search for a Chief Financial Officer as it has accepted the resignation of recent Chief Financial Officer Mark J. Nelson. Until a…
Read More...

Opsis Therapeutics announced that their executive leadership team has approved its scientific advisory board (SAB) responsible to advise on the development and advancement to the…
Read More...

Lamellar Biomedical has raised a fund of £5.75 million in a Series C equity funding round led by Invesco Asset Management Limited and supported by the Scottish Investment Bank (SIB).…
Read More...

Crown Bioscience announced collaboration with Jiangsu Qyun Bio-Pharmaceutical to develop antibody. The goal of the collaboration is to develop a less toxic CTLA-4 antibody and better…
Read More...